Private Equity

Updated:

PE&HR

PE&HR is a private equity and venture capital firm that invests in incubation, start-up, and early-stage companies. The firm primarily focuses on industries...

PE&HR

PE&HR is a private equity and venture capital firm that invests in incubation, start-up, and early-stage companies. The firm primarily focuses on industries such as human resources, internet, healthcare, IT, mobile, and social commerce. PE&HR has made 68 investments, including a Seed VC - II investment in Great Value on August 14, 2025.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

Tokyo, Japan

Sector focus

Industrial TechEnterprise SoftwareAgriTech & FoodTech

Frequently asked questions

What investment stages does PE&HR target?

PE&HR focuses on the earliest stages of company formation — pre-seed, seed, and startup rounds. Its website emphasizes investing during the founding phase of unknown young entrepreneurs. The firm operates multiple thematic funds including Social 2, Social 3, and Social 4, as well as the Saikyo Innovation Fund, all positioned as early-stage vehicles.

How is PE&HR structured differently from a typical Japanese venture capital firm?

PE&HR is a hybrid platform rather than a pure fund manager. Alongside its venture funds, the company operates a human-resources placement business, a management-consulting practice, rental office space, and even a consumer soup brand. This bundling is unusual in Japanese private markets, where venture firms typically remain investment-only entities.

Which sectors does PE&HR explicitly target?

The firm does not publish a restricted sector mandate, but its disclosed portfolio reveals positions in industrial technology — including battery diagnostics and 3D motion analysis — enterprise software, and food products. The Saikyo Innovation Fund, launched with a university partnership, suggests additional focus on deeptech and academic spinouts.

Does PE&HR participate in follow-on rounds or only initial investments?

Available evidence suggests the firm maintains positions through follow-on rounds. Portfolio company Flora completed a funding round in April 2026 that brought its cumulative total to approximately ¥500 million, with PE&HR's Social 3 fund remaining an investor alongside new entrants including Ritsumeikan University and Nagase & Co.

Is PE&HR's platform capital raised from external LPs or proprietary sources?

PE&HR does not disclose the source of its fund capital publicly. No limited-partner base, fundraising timeline, or commitment amounts appear in available materials. The firm's multiple business lines — venture funds, recruitment, consulting, consumer products — suggest at least partial reliance on internally generated capital, but this remains unconfirmed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Tokyo Private Equity profiles